PT1212315E - Novas calconas - Google Patents
Novas calconasInfo
- Publication number
- PT1212315E PT1212315E PT00964042T PT00964042T PT1212315E PT 1212315 E PT1212315 E PT 1212315E PT 00964042 T PT00964042 T PT 00964042T PT 00964042 T PT00964042 T PT 00964042T PT 1212315 E PT1212315 E PT 1212315E
- Authority
- PT
- Portugal
- Prior art keywords
- calconas
- new
- medicament
- prevention
- manufacture
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 230000002265 prevention Effects 0.000 abstract 2
- 208000017657 Menopausal disease Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000001132 Osteoporosis Diseases 0.000 abstract 1
- 230000001028 anti-proliverative effect Effects 0.000 abstract 1
- 210000000481 breast Anatomy 0.000 abstract 1
- 150000001788 chalcone derivatives Chemical class 0.000 abstract 1
- 210000001672 ovary Anatomy 0.000 abstract 1
- 210000004291 uterus Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
- C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
- C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
- C07D311/82—Xanthenes
- C07D311/84—Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
- C07D311/86—Oxygen atoms, e.g. xanthones
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9920910.8A GB9920910D0 (en) | 1999-09-03 | 1999-09-03 | Novel chalcones |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1212315E true PT1212315E (pt) | 2003-08-29 |
Family
ID=10860346
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT00964042T PT1212315E (pt) | 1999-09-03 | 2000-08-28 | Novas calconas |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US6620842B2 (enExample) |
| EP (1) | EP1212315B1 (enExample) |
| JP (1) | JP2003508527A (enExample) |
| KR (1) | KR100819576B1 (enExample) |
| CN (1) | CN1177843C (enExample) |
| AT (1) | ATE235483T1 (enExample) |
| AU (1) | AU776226B2 (enExample) |
| CA (1) | CA2382130A1 (enExample) |
| CZ (1) | CZ2002787A3 (enExample) |
| DE (1) | DE60001851T2 (enExample) |
| DK (1) | DK1212315T3 (enExample) |
| ES (1) | ES2193106T3 (enExample) |
| GB (1) | GB9920910D0 (enExample) |
| HK (1) | HK1043999B (enExample) |
| HU (1) | HUP0202579A3 (enExample) |
| NO (1) | NO20021049L (enExample) |
| PL (1) | PL353064A1 (enExample) |
| PT (1) | PT1212315E (enExample) |
| RU (1) | RU2252938C2 (enExample) |
| SK (1) | SK3112002A3 (enExample) |
| WO (1) | WO2001017988A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003088903A2 (en) | 2002-04-17 | 2003-10-30 | Cytokinetics, Inc. | Compounds, compositions, and methods |
| US7638554B2 (en) * | 2002-04-18 | 2009-12-29 | Sri International | Flavanoids as chemotherapeutic, chemopreventive, and antiangiogenic agents |
| US20030229136A1 (en) * | 2002-04-18 | 2003-12-11 | Nurulain Zaveri | Novel flavanoids as chemotherapeutic, chemopreventive, and antiangiogenic agents |
| DE60326248D1 (de) | 2002-07-17 | 2009-04-02 | Cytokinetics Inc | Verbindungen, zusammensetzungen und verfahren zur behandlung von zellulären proliferativen erkrankungen |
| US6864264B1 (en) | 2002-08-20 | 2005-03-08 | Gloria L. Anderson | 1-adamantyl chalcones for the treatment of proliferative disorders |
| CN100336797C (zh) * | 2005-08-19 | 2007-09-12 | 浙江大学 | 四取代查耳酮衍生物及制备方法和用途 |
| WO2013127361A1 (en) * | 2012-03-01 | 2013-09-06 | The Hong Kong Polytechnic University | Alkyne-, azide- and triazole-containing flavonoids as modulators for multidrug resistance in cancers |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04502322A (ja) * | 1988-12-21 | 1992-04-23 | ジ・アップジョン・カンパニー | 抗アテローム性動脈硬化症性および抗血栓性１―ベンゾピラン―４―オン類および２―アミノ―１，３―ベンゾオキサジン―４―オン類 |
| US5023341A (en) * | 1989-09-19 | 1991-06-11 | Allergan, Inc. | Compounds having a disubstituted acetylene moiety and retinoic acid-like biological activity |
| US4996230A (en) * | 1990-02-16 | 1991-02-26 | Eli Lilly And Company | Leukotriene antagonists |
| JPH05509078A (ja) * | 1990-05-17 | 1993-12-16 | ベイラー カレッジ オブ メディシン | 成長抑制因とガンおよび細胞増殖性疾患措置法 |
| IT1271301B (it) * | 1994-12-20 | 1997-05-27 | Indena Spa | Calconi naturali e sintetici e loro esteri ad attivita' antiproliferativa nei tumori dell'utero,dell'ovaio e del seno e formulazioni che li contengono |
| US5525625A (en) * | 1995-01-24 | 1996-06-11 | Warner-Lambert Company | 2-(2-Amino-3-methoxyphenyl)-4-oxo-4H-[1]benzopyran for treating proliferative disorders |
-
1999
- 1999-09-03 GB GBGB9920910.8A patent/GB9920910D0/en not_active Ceased
-
2000
- 2000-08-28 JP JP2001522211A patent/JP2003508527A/ja not_active Withdrawn
- 2000-08-28 DE DE60001851T patent/DE60001851T2/de not_active Expired - Fee Related
- 2000-08-28 PT PT00964042T patent/PT1212315E/pt unknown
- 2000-08-28 EP EP00964042A patent/EP1212315B1/en not_active Expired - Lifetime
- 2000-08-28 ES ES00964042T patent/ES2193106T3/es not_active Expired - Lifetime
- 2000-08-28 HK HK02105661.5A patent/HK1043999B/en unknown
- 2000-08-28 RU RU2002108566/04A patent/RU2252938C2/ru not_active IP Right Cessation
- 2000-08-28 HU HU0202579A patent/HUP0202579A3/hu unknown
- 2000-08-28 AU AU75109/00A patent/AU776226B2/en not_active Ceased
- 2000-08-28 DK DK00964042T patent/DK1212315T3/da active
- 2000-08-28 PL PL00353064A patent/PL353064A1/xx not_active IP Right Cessation
- 2000-08-28 SK SK311-2002A patent/SK3112002A3/sk unknown
- 2000-08-28 KR KR1020027002798A patent/KR100819576B1/ko not_active Expired - Fee Related
- 2000-08-28 AT AT00964042T patent/ATE235483T1/de not_active IP Right Cessation
- 2000-08-28 CN CNB008123039A patent/CN1177843C/zh not_active Expired - Fee Related
- 2000-08-28 WO PCT/EP2000/008366 patent/WO2001017988A1/en not_active Ceased
- 2000-08-28 CZ CZ2002787A patent/CZ2002787A3/cs unknown
- 2000-08-28 CA CA002382130A patent/CA2382130A1/en not_active Abandoned
-
2002
- 2002-02-15 US US10/075,626 patent/US6620842B2/en not_active Expired - Fee Related
- 2002-03-01 NO NO20021049A patent/NO20021049L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ATE235483T1 (de) | 2003-04-15 |
| AU7510900A (en) | 2001-04-10 |
| DE60001851D1 (de) | 2003-04-30 |
| ES2193106T3 (es) | 2003-11-01 |
| AU776226B2 (en) | 2004-09-02 |
| HUP0202579A2 (hu) | 2002-11-28 |
| JP2003508527A (ja) | 2003-03-04 |
| EP1212315B1 (en) | 2003-03-26 |
| NO20021049L (no) | 2002-05-03 |
| CN1371372A (zh) | 2002-09-25 |
| US20030055056A1 (en) | 2003-03-20 |
| DK1212315T3 (da) | 2003-06-23 |
| SK3112002A3 (en) | 2003-10-07 |
| NO20021049D0 (no) | 2002-03-01 |
| WO2001017988A1 (en) | 2001-03-15 |
| GB9920910D0 (en) | 1999-11-10 |
| HUP0202579A3 (en) | 2003-07-28 |
| RU2252938C2 (ru) | 2005-05-27 |
| PL353064A1 (en) | 2003-10-06 |
| US6620842B2 (en) | 2003-09-16 |
| KR20020031598A (ko) | 2002-05-02 |
| CZ2002787A3 (cs) | 2002-06-12 |
| EP1212315A1 (en) | 2002-06-12 |
| HK1043999A1 (en) | 2002-10-04 |
| CN1177843C (zh) | 2004-12-01 |
| DE60001851T2 (de) | 2003-12-11 |
| HK1043999B (en) | 2003-08-15 |
| KR100819576B1 (ko) | 2008-04-22 |
| CA2382130A1 (en) | 2001-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1233770A4 (en) | PHOSPHONATE COMPOUNDS | |
| PL367682A1 (en) | Dolastatin 10 derivatives | |
| ATE303359T1 (de) | Biphenylverbindungen und biphenyl-analoge als intergrin-antagonisten | |
| TR200003735T2 (tr) | Osteoporoz ve menopoz sendromuna bağlı rahatsızlıkların önlenmesi ve tedavileri | |
| TNSN05045A1 (en) | Indole or benzimidazole derivatives for modulating ikappab kinase | |
| MY141661A (en) | 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | |
| ATE236147T1 (de) | Derivate von flavonen, xanthonen und kumarinen | |
| MXPA04004674A (es) | Ligados de los receptors de los canabinodies. | |
| MY128659A (en) | Novel aminodicarboxylic acid derivatives having pharmaceutical properties | |
| TR200101969T2 (tr) | Enflamasyon tedavisi için sübstitüe edilmiş benzopiran analogları. | |
| GB0225475D0 (en) | Therapeutic agents | |
| MY140080A (en) | Treatment and prevention of osteoporosis | |
| MXPA04003087A (es) | Derivados de cromano como ligados de 5-hidroxitriptamina-6. | |
| ATE241641T1 (de) | Betulinsäure derivate zur behandlung von neuroektodermalen tumoren | |
| AP2000001898A0 (en) | Vitronectin receptor antagonists | |
| UA72948C2 (uk) | Заміщені похідні фенілпіперазину, фармацевтична композиція та спосіб лікування афективних або неврологічних захворювань і розладів | |
| DK0989973T3 (da) | Chalconer med antiproliferativ aktivitet | |
| PT1212315E (pt) | Novas calconas | |
| BR9917495A (pt) | Derivados o ácido betulìnico tendo atividade antiangiogênica, processos para produzir tais derivados e sua utilização para o tratamento de antiogênese associada a tumores | |
| NO20014241D0 (no) | C16-umettede FP-selektive prostaglandinanaloger | |
| AP9801202A0 (en) | Atropisomers of 3-heteroaryl-4(3H)-quinazolinones. | |
| DE69917005D1 (de) | Substituierte pyrrolobenzimidazolderivate zur entzündungshemmung | |
| MXPA04000805A (es) | Peptidos que tienen actividad antiangiogenica. | |
| ATE346036T1 (de) | Antiangiogene substanz zur behandlung von krebs, arthritis und netzhauterkrankungen | |
| IT1289154B1 (it) | Derivati di isoflavone loro preparazione e loro impiego terapeutico |